002737SZSE

2025 Annual Audit Report

Sunflower Pharmaceutical Group Co., Ltd.··140 pages

✨ AI Summary

This report provides the 2025 annual audit opinion for Ma Hua Pharmaceutical Group Co., Ltd. The audit confirms that the financial statements present a true and fair view of the company's financial position as of December 31, 2025, and its performance for the year. Key figures show total assets of RMB 617,433,352.73 and net income of RMB 107,664,416.21. The material outcome is the unqualified audit opinion, stating compliance with the applicable financial reporting framework.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openaiSign In to Upgrade

Audit Report

We have audited the financial statements of [Company Name], which comprise the consolidated balance sheet as of December 31, 2025, and the consolidated income statement, consolidated cash flow statement, and the statement of changes in equity for the year ended December 31, 2025, and the related notes to the financial statements.

Table of Contents

SectionTitlePage
1Audit Report1-5
2Financial Statements1-121
2.1Consolidated Balance Sheet1-4
2.2Consolidated Income Statement5-6
2.3Consolidated Cash Flow Statement7-8
2.4Statement of Changes in Equity9-12
3Notes to Financial Statements1-121

Audit Opinion

We have audited the financial statements of [Company Name] as of December 31, 2025, which include the consolidated balance sheet, consolidated income statement, consolidated cash flow statement, and the statement of changes in equity. In our opinion, the financial statements present a true and fair view of the financial position of the company as of December 31, 2025, and its financial performance and cash flows for the year then ended in accordance with the applicable financial reporting framework.

Basis for Audit Opinion

We conducted our audit in accordance with the auditing standards established by the Chinese Institute of Certified Public Accountants. Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit in China, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.